India's preferred Personal finance destination
Home Shares F&O Mutual Funds IPO Commodity Portfolio Financial Planning Insurance Loans News Centre About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker Newsletter Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 141.30 4.40
Tata Mot 428.65 4.24
Bhel 181.05 3.10
Tata Stl 418.80 1.22
Ntpc Ltd 123.05 0.37
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
 
News-Sanofi India Limited
Sanofi India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500674NSE:SANOFIBloomberg:SANL@INReuters:AVPH.BO
Market Lot: 1Face Value: 10ISIN Demat: INE058A01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
15-Apr-2014       N Rajaram joins Sanofi as country head and general manager IRIS
12-Nov-2013       Sanofi partners with PVR Nest for student-led campaign IRIS
30-Sep-2013       Sanofi, IDF, PHFI partner to fight diabetes among children IRIS
05-Aug-2013       Sanofi to use renewable energy for Ankleshwar unit IRIS
10-Jul-2013       Sanofi India board to consider interim dividend on July 30 IRIS
03-Jul-2013       Sanofi India announces resignation of J. M. Gandhi IRIS
15-Feb-2013       Sanofi India rallies after HC ruling on Shantha-tax case IRIS
15-Feb-2013       Sanofi will not have to pay tax in India, rules HC IRIS
24-Feb-2012       `Sell` Aventis; target Rs 1,937: Angel Broking IRIS Exclusive
23-Feb-2012       Aventis Pharma Q4 profit drops 66% IRIS
04-Nov-2011       Aventis Pharma completes acquisition of Universal Medicare IRIS
24-Aug-2011       Aventis Pharma up on acquisition news IRIS
24-Aug-2011       Aventis Pharma to acquire Universal Medicare`s nutraceutical unit IRIS
01-Aug-2011       Motilal Oswal maintains `Neutral` on Aventis Pharma  IRIS Exclusive
29-Jul-2011       Angel Broking maintains `Reduce` on Aventis Pharma  IRIS Exclusive
27-Apr-2011       Aventis Pharma earnings jump 40.17% for Mar`11 qtr IRIS

 

 

Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer